Medicine and Dentistry
Intensive Care Unit
100%
Cohort Analysis
63%
Intensive Care
45%
Out of Hospital Cardiac Arrest
43%
COVID-19
43%
Resuscitation
22%
Extracorporeal Membrane Oxygenation
22%
Observational Study
22%
Assisted Circulation
22%
Cardiogenic Shock
21%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Frailty
17%
Extracorporeal
17%
Artificial Respiration
15%
Systematic Review
15%
Heart Arrest
15%
Mortality Rate
15%
Adverse Outcome
12%
Intensive Care Medicine
12%
Thrombocyte Function
12%
Renal Replacement Therapy
11%
Acute Kidney Injury
11%
Placebo
11%
SAPS II
11%
Return of Spontaneous Circulation
9%
Randomized Clinical Trial
9%
Quality of Life
9%
Functional Status
9%
Life Sustaining Treatment
9%
Low Drug Dose
8%
Adverse Event
8%
Disease
8%
Chronic Obstructive Pulmonary Disease
8%
Sepsis
8%
Isotopes of Calcium
7%
Hydrocortisone
7%
Nonsteroid Antiinflammatory Agent
7%
Hypoxia
7%
Elderly Patient
7%
Vascular Access
7%
Continuous Positive Airway Pressure
7%
Hemodynamic
7%
Thrombocyte Aggregation
6%
Platelet
6%
Bleeding
6%
Triage
6%
Odds Ratio
6%
Heart Failure
6%
Population
6%
Perforated Ulcer
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
38%
Case-Control Study
19%
Venous Thromboembolism
15%
Comorbidity
15%
Disease
13%
SARS Coronavirus
13%
Glucocorticoid
11%
Replacement Therapy
10%
Placebo
10%
Mortality Rate
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
9%
Coronavirinae
8%
Acute Kidney Failure
8%
Non-Steroidal Anti-Inflammatory Drug
7%
Statin (Protein)
7%
Multiple Sclerosis
7%
Bisphosphonic Acid Derivative
7%
Adverse Outcome
7%
Chronic Obstructive Lung Disease
7%
Piperacillin
7%
Subarachnoid Hemorrhage
7%
Hydrocortisone
7%
Hypoxia
7%
Pharmacokinetics
7%
Heart Failure
7%
Infection
6%
Respiratory Failure
5%
Atrial Fibrillation
5%
Cardiogenic Shock
5%
Observational Study
5%
Nursing and Health Professions
Intensive Care Unit
40%
Intensive Care
33%
Cohort Analysis
18%
Comorbidity
8%
Mortality Rate
8%
Confidence Interval
7%
Artificial Respiration
5%
Odds Ratio
5%
Disease
5%
Rate Ratio
5%
